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A B S T R A C T
This retrospective study is based on the analysis of 542 snakebite envenomation cases in southern Croatia, which were
treated in the University Hospital Split over the period of 21 years. The aim of this study was to determine the incidence
of venomous snakebite in southern Croatia, epidemiological and clinical features of snakebite and treatment in the re-
gion. The mean annual snakebite incidence in southern Croatia was 5.2 per 100,000 inhabitants. The nose- horned viper
(Vipera ammodytes) was responsible for most bites, only a small proportion being inflicted by the adder (Vipera berus).
People of all ages were affected (1 – 82 year old), but the bites were more frequent in individuals older than 50 (46% of the
cases) and in children and adolescents 19 year old and younger (27% of the cases). Most snakebite accidents happened in
warm spring and summer months, the highest number occurring in May (22%). A majority of the victims were rural peo-
ple engaged in agricultural activities. Bites on the upper limbs were more frequent (57%) than bites on the lower limbs
(42%). With regard to envenomation severity, there were 15.1% minor, 40.5% mild, 26% moderate and 18% severe cases.
Two victims died (0.4%). The antivenom produced by the Institute of Immunology in Zagreb was given to virtually all
patients, and complications following its administration were rare. The antivenom was used more often than it was sug-
gested by the symptoms present.
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Introduction
Venomous snakebites are common in tropical and
subtropical regions, but they also occur in regions with
temperate climates1–4. The only venomous snakes in Eu-
rope are viperids (belonging to the family Viperidae), spe-
cifically »true« vipers (Viperinae subfamily)5. Croatia is
situated in a region of Europe where vipers are abun-
dant. Europe’s most venomous snake, the nose-horned
viper, Vipera ammodytes, is frequently encountered in
dry, rocky areas of southern Croatia6. Most of its victims
are rural people engaged in agricultural activities. V.
ammodytes delivers on average 20 mg of dry venom in a
single bite, which is considered to be a lethal dose for hu-
mans. The bites of the adder (V. berus) in Croatia are
much less frequent5. The venoms of V. ammodytes and V.
berus, as well as the venoms of other Viperinae, are
largely necrotising and hemorrhagic, and only to a lesser
degree neurotoxic. These venoms contain active protein
substances (enzymes and toxins) with different mecha-
nisms of activity5,7. At the time of envenomation a potent
inoculum of aerobic and anaerobic bacteria is introduced
by the snake’s fangs. These bacteria can cause serious in-
fections in necrotic tissue at the bite site4,5. Most studies
carried out so far in Europe deal with snakebites caused
by V. berus and V. aspis1,3,8,9. Hence, it was very interest-
ing to conduct research in a region where the bites are in-
flicted primarily by V. ammodytes.
In this paper, we present the incidence of venomous
snakebite, epidemiological trends, clinical manifestation,
and snakebite treatment in southern Croatia.
Patients and Methods
This study is retrospective, and the source of data is
the medical records of the snakebite patients that re-
ceived treatment at the University Hospital of Split (UH)
(southern Croatia) over the period of 21 years (from Jan-
uary 1, 1982, to December 31, 2002). The study covered
Split-Dalmatia County in southern Croatia, which is in-
habited by 496,395 people (according to 1991 census)10.
By convention, almost all snakebite cases in this region
are sent to the Department of Infectious Diseases at the
UH Split. After a snakebite victim is brought to the de-
partment, he or she is examined by an infectious disease
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specialist, who determines whether or not the venom was
injected. Only venomous bite cases are hospitalized. The-
re were likely some mild cases of snakebite envenom-
ation which were not registered, because the patients did
not visit the hospital. In most cases, a physician identi-
fied the snake involved based on the data given by the pa-
tients or their companions. Therefore, it was possible
that in some cases the responsible species was misidenti-
fied. In certain cases the physician identified the snake
involved by observing the killed snake brought to the
hospital. The data gathered from the medical records of
the patients were assigned to demographic, epidemiologi-
cal, clinical, laboratory and treatment categories. Zagreb
antivenom was the sole antivenom used in treatment.
The data were analyzed in Statistica 6.0 (StatSoft, Inc.,
Tulsa, OK, USA). A portion of the snakebite data from
the medical records of the UH Split were also used in an-
other study by Radoni} et al., 19977.
The mean annual snakebite incidence in southern
Croatia was obtained in the following way. For a particu-
lar year, the incidence was calculated by dividing the
number of snakebite victims treated at the hospital with
the number of residents of the region, and then by multi-
plying this result by a constant (100,000). The incidence
values for all years were added and the sum obtained was
divided by 21 (the study period of 21 years), which gave
the mean annual snakebite incidence per 100,000 inhab-
itants.
For the classification of the nose-horned viper and ad-
der bite reaction, we used the scheme devised by Reid
(1976) and modified by Persson (1981):
¿ Minor reaction-local oedema, no general symptoms
and signs except those of fright.
¿ Mild reaction-local or more extensive oedema, with
or without gastrointestinal signs and symptoms but
without other systemic effects.
¿ Moderate reaction-extensive oedema, shock lasting
for less than two hours, other signs and symptoms
of moderate poisoning.
¿ Severe reaction-shock lasting for more than two
hours or recurring episodes of shock, other signs
and symptoms of severe systemic poisoning.
¿ Fatal reaction-more evident systemic poisoning
ending in death of the patients1,11,12.
Results
Epidemiological data
The mean annual snakebite incidence in southern
Croatia was 5.2 per 100,000 inhabitants. This snakebite
incidence would have likely been higher if the mild en-
venomation cases which did not visit the hospital had
been documented. Two snakebite deaths were recorded
(0.4%). In one case, the individual was bitten in the neck
while sleeping in a sleeping bag. The other individual
was bitten in the armpit region while resting with the
hand put on a dry-stone wall. It is likely that the venom
was injected directly into a blood vessel, which would
lead to toxic shock. It is important to point out that these
two fatalities occurred during military operations in 1993,
and that the victims did not receive adequate medical
treatment7. The bites of V. ammodytes were much more
frequent than the bites of V. berus. In 9% of the snakebite
cases we could positively identify the species based on the
dead specimen brought to the hospital, and in these cases
the ratio of V. ammodytes to V. berus specimens was 16:1.
In the remaining cases, 11% of them did not see the
snake at all, 45% saw the snake, but did not recognize it,
33% believe they were bitten by V. ammodytes, and 2%
believe to be bitten by V. berus. People of all ages suffered
bites (1 to 82 years of age), but the bites were more fre-
quent in individuals older than 50 (252 cases or 46%) and
in children and adolescents 19 year old and younger (148
cases or 29%) (Figure 1). We found the following profes-
sions or groups of people to be especially vulnerable to
snakebites. At highest risk were the rural people engaged
in agricultural activities (planting, harvesting, etc), com-
prising 45% of the cases. Other vulnerable groups were
cattle-breeders (10%), people gathering wood (7%) and
those gathering wild edible plants such as blackberries
and asparagus (5%). The children were bitten while play-
ing outdoors (12%). The remaining 21% of the cases in-
cluded tourists, backpackers, mountain climbers, hunt-
ers, soldiers and individuals who keep venomous snakes










































































































Fig. 2. Monthly distribution of 542 venomous snakebites.
as pets. There was an almost equal number of men and
women affected by snakebites (51% and 49%, respec-
tively). Most bites occurred during warm spring and
summer months (504 cases or 93%), the most hazardous
month being May (119 cases or 22%) (Figure 2). During
colder months (February, March, October and Novem-
ber) snakebites were very rare (1–23 cases or 0.2–4.2%).
In December and January no snakebite accidents oc-
curred (Figure 2). Bites on the upper limb were more fre-
quent (57%) than bites on the lower limb (42%). The
bites on the head, neck, armpit and gluttonous region oc-
curred rarely, a single victim in each case.
Clinical data
Symptoms and signs of V. ammodytes and V. berus
bites are reported in Table 1. Swelling at the bite site was
recorded in all patients. The extent of swelling varied
from barely noticeable to massive, which spread rapidly
over the entire limb and also affected the trunk (Figure
3). Extensive oedema was present in 46.8% of the pa-
tients. The extent of swelling was estimated based on the
observation of the affected area. Discoloration of skin
and ecchymosis were recorded in 92.2% of patients, also
varying in extent from minor and barely noticeable to ex-
tensive, affecting the entire limb and also the trunk (Fig-
ure 3). Regional lymphadenitis was present in 45% of the
patients.
Other local effects included hemorrhagic blisters (13%
of the cases), skin and muscle necrosis (3.8%), throm-
bophlebitis (2%), compartment syndrome (CS) (1.8%)
and infection (cellulitis or abscess) (0.9%). Different sizes
of hemorrhagic blisters were observed, from the size of a
pea to the size of a walnut and even larger (Figure 4). In
most cases, the incision of a hemorrhagic blister was per-
formed. Early debridment was carried out only when the
skin and muscles necrosis were extensive. Thrombo-
phlebitis of the blood vessels near the bite site occurred
more often in the elderly and more often in cases in
which the bite was on the leg. The diagnosis of CS was
based on the observation of the clinical signs and symp-
toms of the syndrome, since the instrument for measur-
ing compartment pressure was not available. Of the 10
(1.8%) CS cases, there were two cases of small children in
shock in which the diagnosis of CS was controversial. CS
occurred mostly in children, and upper extremities were
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TABLE 1








Skin discoloration and ecchymosis 500 92.2
Regional lymphadenitis 244 45.0
Hemorrhagic blisters 71 13.0
Skin and muscle necrosis 21 3.8
Infection (cellulitis, apscess) 5 0.9
Thrombophlebitis 11 2.0
Compartment syndrome 10 1.8
Gastrointestinal symptoms 122 22.5
Shock 28 5.1
<2 hours 17 3.1
2 hours 11 2.0
Central nervous system depression 32 5.9
Slight 27 5.0
Unconsciousness 5 0.9
Cranial nerve paresis/paralysis 87 16.0
Fever 330 60.8
Liver damage 24 4.4









Fig. 3. Vipera ammodytes bite on the right hand finger in a 78-
year-old female. Oedema, discoloration of skin and ecchymosis of
the whole arm and a part of the body.
more affected than lower extremities. Fasciotomies were
performed for all CS diagnosed (Figure 5).
Gastrointestinal symptoms (vomiting and diarrhea)
were the most common systemic effects, occurring in
22.5% of the patients.
The neurotoxic component of the venom is the cause
of the cranial nerve paresis or paralysis in 16% of the
cases. The most frequent was the paresis or paralysis of
the oculomotor nerve, which was manifested by palpa-
bral ptosis (Figure 6). The paresis or paralysis of the
abducens, glossopharyngeal, and other cerebral nerves,
which were manifested by ophthalmoplegia, dysphagia
and dysphonia, were less frequent.
Various degrees of central nervous system (CNS) de-
pression were recorded in 32 (5.9%) cases, and 20 of
these cases had shock and hypotension. The remaining
12 CNS depression cases did not have hypotension. Of
these 12 cases, 6 had CNS depression only, and 6 had
both CNS depression and cranial nerve paralysis or pare-
sis.
Shock occurred in 5.1% of the patients, 2% of whom
had hypotension for more than two hours.
Leucocytosis (white blood cell count 10  109/L) was
present in 36.1% of the patients, 10% of the patients hav-
ing a white blood cell count of more than 15  109/L. Ane-
mia was present in 6.4%, thrombocytopenia in 2% and
prolonged prothrombin time in 2.2% of the patients.
Bleeding also occurred, mostly from the urinary tract
(8.8%), and less frequently from the intestinal (1.9%) and
respiratory tracts (0.9%). Bleeding was usually mild,
mostly not requiring blood transfusions.
Renal failure (oliguria, proteinuria, elevated serum
creatinine) was recorded in 4.6% of the patients, and
mostly occurred in patients with shock. Liver damage
(increased bilirubin, aspartate aminotransferase, alanine
aminotransferase) was recorded in 4.4% of the patients.
Renal failure and liver damage were temporary, with
most patients having recovered by the time they left the
hospital.
The body temperature was elevated in 60.8% of the
patients, but in most cases it did not exceed 38 °C. Only 5
patients (0.9%) had fever that exceeded 38 °C.
With regard to the severity of envenomation there
were 15.1% minor, 40.5% mild, 26% moderate and 18%
severe cases. The average duration of hospitalization was
2.6, 5.8, 8.9 and 10.9 days for these four groups, respec-
tively. Two victims died (0.4%) (Table 2).
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Fig. 5. Dorsal fasciotomy of the forearm and the hand 6 hours
after Vipera ammodytes bite in a 12-year-old boy.
Fig. 6. Paresis of the oculomotor nerve (palpabral ptosis) in a
4-year-old child.
Fig. 4. A large hemorrhagic blister at the bite site in a 58-year-
-old woman bitten in the right hand finger.
Treatment
Approximately one-fourth of the patients used first
aid, specifically, a constricting band (16.4% of the pa-
tients), incision (6%), suction at the bite site (4.6%), and
immobilization (2%). 93% of the patients received expert
medical help within two hours after being bitten. Virtu-
ally all patients received the antivenom (99%), tetanus
prophylaxis (98%) and antibiotics (97%). In addition, a
large number of patients received antihistamines (73%)
and corticosteroids (78%). Remarkably, 94% of the pa-
tients received the first dose of the antivenom within
four hours after the bite. 77% of the patients received
one dose of the antivenom, and 22% received two or three
doses. A total of 783 doses of the antivenom were used on
540 patients, and only one case of anaphylactic shock was
recorded (0.2%). Furthermore, three cases of serum sick-
ness occurred (0.6%). Of the antibiotics used, penicil-
lin-based products were most frequently administered.
Virtually all patients received the tetanus prophylaxis,
and no tetanus cases occurred. 17% of the cases required
surgical intervention, which most frequently included
the incision of hemorrhagic blister (12%), then early
debridment of superficial necrosis (3.2%) and fasciotomy
(1.8%) (Figure 5). All of our surgically treated patients
recovered successfully.
Discussion
In southern Croatia snakes are active from the end of
winter to late autumn5. A majority of the bites were re-
corded in May and in summer months (June, July, Au-
gust) because these are the months when the vipers are
most active, and when people are very much engaged in
agricultural activities in southern Croatia. Other Euro-
pean countries show a similar seasonal trend in the fre-
quency of bites, but there is a difference with respect to
the most hazardous month1,3,11–13. For example, in south-
ern Croatia the highest number of bites happened in
May, whereas in Spain this was in June, and in Italy in
August12,13. V. ammodytes bites in this region were much
more common than V. berus bites, because V. ammodytes
is very widespread, whereas V. berus has only a very lim-
ited distribution confined to the peripheral regions of the
county5. V. ammodytes is especially dangerous when climb-
ing trees in search of food because of a high risk of inflict-
ing bites on the head and the neck5,6. The bites on the
neck and the head, as well as the bites directly into a
blood vessel, are extremely dangerous. The injection of
the venom into a blood vessel commonly leads to toxic
shock, which may easily prove fatal, although this is not
the rule5,7. The bites on the upper extremity took place
more often than the bites on the lower extremity, mostly
because of traditional agricultural work procedures, which
involve the use of bare hands and traditional, non-mech-
anized equipment. Swiss, Italian and Spanish studies
also found the bites on the upper extremity to be more
frequent than the bites on the lower extremity. On the
contrary, a Swedish study found the bites on the lower
extremity to be more common3,11,12,14. The bites occurred
most frequently in children, adolescents and older indi-
viduals, which was also found to be true in other studi-
es5,11,15. Children and adolescents were frequently bitten
while playing outdoors (in fields), and older individuals
were bitten while being engaged in agricultural activi-
ties.
The clinical symptoms that appear following the bite
of V. ammodytes or V. berus are mainly a result of the
hematotoxic effects of the venom, and only to a smaller
degree of the neutrotoxic effects5,13. All of the patients
had swelling and over 90% had discoloration of skin and
ecchymosis. Swelling, skin discoloration and ecchymosis,
which occur soon after the venom is injected (within 4
hours), are used to distinguish a venomous from a non-
venomous bite5,16.
Massive swelling at the bite site leads to increased tis-
sue pressure within the closed bonefascial space on the
extremity, which may result in CS5,7,17,18. This is usually
the case in children because of a larger quantity of venom
per unit of body weight. In determining clinical diagnosis
of CS and deciding on the use of fasciotomy we should be
utterly cautious, because the surgical intervention itself
can cause complications and permanent disability. Fas-
ciotomy should only be carried out in patients with clinical
symptoms and signs of compartment syndrome (painful
passive stretch, hypoesthesia, compartment tenseness,
and weakness), and measured compartment pressure
over 30 mmHg (provided the instrument for measuring
pressure is available). Fasciotomy should never be per-
formed prophylactically7,15,18,19. In other studies on Euro-
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TABLE 2
DISTRIBUTION OF THE 542 PATIENTS BY SEVERITY OF ENVENOMATION
Reaction
Age group (years) Total Days in hospital
(average)0–9 10–19 20–59 > 60 Number (%)
Minor 4 12 43 23 82 (15.1) 2.6
Mild 32 36 92 60 220 (40.5) 5.8
Moderate 17 21 51 51 140 (26) 8.9
Severe 13 13 43 29 98 (18) 10.9
Fatal 0 0 2 0 2 (0.4) 0
pean viper bites, CS was either not recorded at all or it
was found very rarely1,3,8,9,12,19.
In this study in which V. ammodytes bites were pre-
dominant, there was a fairly large number of patients
with clinically manifested neurological disturbances as a
result of the neurotoxic effects of the venom. Specifically,
87 (16%) of our patients had cranial nerve paresis or pa-
ralysis (ptosis, ophthalmoplegia, dysphagia), and 6 (1.1%)
of our patients had CNS depression only, without shock,
hypotension, or cranial nerve paresis or paralysis. This
indicates that the venom not only has direct neurotoxic
action on cranial nerves, but it is also likely to have a pri-
mary toxic action on CNS as well.
The average duration of hospitalization in our study
was longer than the averages reported in other stu-
dies11,12, and it was correlated with the severity of enven-
omation. The frequency of moderate and severe enven-
omation in our study was much higher than that re-
ported in other studies. For example, we report 44% of
moderate and severe cases of envenomation, whereas the
Swedish authors reported 27% of such cases, Italian 23%
and French 25%8,11,12. A higher frequency of moderate
and severe cases of envenomation in this study could be
attributed to the fact that most bites in southern Croatia
were inflicted by V. ammodytes, which delivers more
venom and causes more severe envenomation than V.
berus and V. aspis do.
The envenomation by V. ammodytes and V. berus is a
medical emergency that requires urgent treatment, in-
cluding first aid in the field and expert treatment at a
medical center. In the field, the victim should be reas-
sured, the bite site cleaned and the limb immobilized.
Most importantly, the victim must be transported to the
nearest medical center as soon as possible5,6,16. Older
practices such as applying a tourniquet, making incisions
at the bite site and sucking the venom out are no longer
recommended16. At a medical center, the extent of swell-
ing should be closely observed and monitored as well as
the development of other symptoms and signs of enven-
omation. If the swelling spreads rapidly, or if the patient
develops systemic signs of envenomation (shock, uncon-
sciousness, severe gastrointestinal symptoms), antiven-
om should be administred5,7,16. In our region we recom-
mend giving antivenom to patients with moderate and
severe envenomation at the medical center. It should not
be given to patients having mild and minor enveno-
mation13,14,16,20–22. The antivenom should be adminis-
tered intravenously13,16,20. The efficacy of the antivenom
is the highest if it is administered within 4 hours after
the bite, and in which case one dose of the antivenom is
usually sufficient (10 ml). If envenomation is severe, two
to four antivenom doses need to be used (20–40 ml)20. We
used only Zagreb antivenom, and found complications
following its administration to be very rare. In contrast,
some authors found that complications were not uncom-
mon following the use of Zagreb antivenom and other
equine antivenoms3,9,12,13,23.
Following the treatment with antivenom, tetanus
prophylaxis should be administered, depending on the
immunological status of the patient to tetanus4,13,24. In
the past, a number of authors recommended the use of
antibiotics prophylactically after the snakebite in all
cases6,13,25, but this is no longer recommended4. Antibi-
otics should only be given in the event of infection (ac-
cording to the identity of the pathogen and its suscepti-
bility to the antibiotic)4. The use of antihistamines and
corticosteroids, previously advocated by some authors, is
no longer recommended1,5,13,27,28. Corticosteroids are only
used to treat allergic reactions to the serum, and some
authors use them to treat CS1,6,19,28. If the patient is in
shock or his or her general condition is severely altered,
he or she should be transported to the intensive care unit,
where all the necessary treatments need to be carried out,
including the administration of infusion solutions, blood,
sedatives, anticonvulsants, mechanical ventilation, hemo-
dialysis, surgical intervention, etc7–9,13,16,17,29.
In this study, the antivenom and particularly antibiot-
ics, antihistamines and corticosteroids were used more of-
ten than it was suggested by the symptoms present.
However, the use of these medicines should be limited to
cases in which sufficient indication for their use exists, as
it is described in the text.
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UGRIZI ZMIJA OTROVNICA U JU@NOJ HRVATSKOJ
S A @ E T A K
U retrospektivnoj studiji prikazana su 542 bolesnika otrovana zmijskim otrovom u ju`noj Hrvatskoj, koji su lije~eni
u Klini~koj Bolnici Split kroz 21-godi{nje razdoblje. Cilj rada bio je utvrditi incidenciju ugriza otrovnica u ju`noj Hrvat-
skoj, te prikazati epidemiolo{ka obilje`ja, klini~ku prezentaciju i na~ine lije~enja otrovanja zmijskim otrovom na ovom
podru~ju. Prosje~na incidencija ugriza otrovnica u ju`noj Hrvatskoj iznosila je 5,2/100 000 stanovnika godi{nje. Ugrizi
poskoka (Vipera ammodytes) su bili ~e{}i od ugriza ri|ovke (Vipera berus). Od ugriza su stradavale sve dobne skupine
(od 1–82 godina), a naj~e{}e (46%) stariji od 50 godina, te djeca i adolescenti u dobi od 0–19 godina (27%). Ve}ina ugriza
dogodila se tijekom toplih mjeseci prolje}a i ljeta, naj~e{}e u svibnju (22%). Od ugriza otrovnica uglavnom je stradavalo
seosko pu~anstvo obavljaju}i poljoprivredne radove. Ugrizi u ruku su bili ~e{}i (57%) nego ugrizi u nogu (42%). Prema
te`ini otrovanja bilo je 15,1% bolesnika s vrlo blagim oblikom otrovanja, 40.5% s lakim, 26 % sa srednje te{kim i 18% s
te{kim oblikom otrovanja. Smrtno su stradala dva bolesnika (0,4%). Gotovo svi bolesnici su primili antiviperini serum
(proizvo|a~ Imunolo{ki zavod u Zagrebu), a komplikacije nakon njegove primjene su bile rijetke. Antiviperini serum se
koristio ~e{}e nego je za to postojala stvarna indikacija.
